|
ZNF442 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.398400E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.421610E-02 |
| Normal-vs-Stage2 |
3.620400E-01 |
| Normal-vs-Stage3 |
1.561630E-03 |
| Normal-vs-Stage4 |
3.260400E-03 |
| Stage1-vs-Stage2 |
1.470240E-01 |
| Stage1-vs-Stage3 |
1.328630E-01 |
| Stage1-vs-Stage4 |
2.705000E-01 |
| Stage2-vs-Stage3 |
1.999590E-02 |
| Stage2-vs-Stage4 |
4.956300E-02 |
| Stage3-vs-Stage4 |
9.699400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.535300E-03 |
| Normal-vs-AfricanAmerican |
2.854000E-01 |
| Normal-vs-Asian |
5.663900E-03 |
| Caucasian-vs-AfricanAmerican |
2.764200E-01 |
| Caucasian-vs-Asian |
7.412200E-01 |
| AfricanAmerican-vs-Asian |
3.043400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.220300E-02 |
| Normal-vs-Female |
4.442200E-03 |
| Male-vs-Female |
1.117190E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.811530E-02 |
| Normal-vs-Age(41-60Yrs) |
5.476000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.871800E-02 |
| Normal-vs-Age(81-100Yrs) |
3.664200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.357800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.765200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.717000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.321000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.606600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.989200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.618150E-02 |
| Classical-VS-Follicular |
1.552210E-02 |
| Classical-VS-Other |
4.627600E-01 |
| Classical-VS-Normal |
7.236800E-03 |
| Tall-VS-Follicular |
2.556400E-04 |
| Tall-VS-Other |
4.095400E-01 |
| Tall-VS-Normal |
1.609720E-04 |
| Follicular-VS-Other |
2.632200E-02 |
| Follicular-VS-Normal |
4.792800E-01 |
| Other-VS-Normal |
9.777900E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.471960E-02 |
| Normal-vs-N1 |
1.792440E-04 |
| N0-vs-N1 |
4.637700E-03 |
|
|
